Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia

Editor

8 years ago

Michelle Dawson, MD, AstraZeneca, talks about Moxetumomab Pasudotox Pivotal in relapse refractory hairy cell leukemia at Annual Meeting 2018.